Region-Based Analysis of Prevalence and Incidence of Parkinson’s Disease: Analysis of the National Sample Cohort in South Korea

다국어 초록 (Multilingual Abstract)

Background and Purpose The rapid increases in the elderly population and urbanization in South Korea have influenced both demographics and the environment. This study investigated trends in the prevalence and incidence of Parkinson’s disease (PD), and the associations of PD with the urban and rural environments in South Korea.
Methods This study examined subjects aged 40 years or older in a cohort constructed using the National Sample Cohort data set in South Korea during 2002–2013. We estimated the age-standardized prevalence and incidence of PD based on the 2002 population, and estimated their trends. We analyzed regional differences in these rates by dividing South Korea into three regions based on geographic characteristics and two regions based on the degree of urbanization.
Results The standardized prevalence rates of PD per 100,000 increased significantly from 75.8 in 2003 to 136.8 in 2012 (p<0.0001), especially in older subjects. The standardized prevalence of PD was highest in metropolitan Seoul. The standardized incidence of PD per 100,000 was 13.9 in 2003 and 10.3 in 2012, with no significant trend (p>0.05). The standardized incidence of PD in younger subjects was lower in eastern Korea than in the other two regions, while in the older subjects it was lower in western Korea than in metropolitan Seoul over almost the entire analyzed period. The standardized incidence of PD did not differ significantly between metropolitan and nonmetropolitan areas.
Conclusions The standardized prevalence of PD increased steadily from 2003 to 2012 in South Korea, while its standardized incidence has remained constant. There were regional differences in the prevalence and incidence of PD based on the degree of urbanization and the area of agricultural land.

참고문헌 (Reference)

1 탁한명, "지형학적 산지의 분포와 공간적 특성에 관한 연구" 대한지리학회 48 (48): 1-18, 2013

2 Gupta A, "What causes cell death in Parkinson's disease?" 64 (64): S3-S15, 2008

3 Findley LJ, "The economic impact of Parkinson's disease" 13 (13): S8-S12, 2007

4 Dorsey ER, "The coming crisis: obtaining care for the growing burden of neurodegenerative conditions" 80 : 1989-1996, 2013

5 Hughes AJ, "The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service" 125 : 861-870, 2002

6 Armitage P, "Tests for linear trends in proportions and frequencies" 11 : 375-386, 1955

7 Palin O, "Systematic review and meta-analysis of hydrocarbon exposure and the risk of Parkinson's disease" 21 : 243-248, 2015

8 Elbaz A, "Survival study of Parkinson disease in Olmsted County, Minnesota" 60 : 91-96, 2003

9 Cochran WG, "Some methods for strengthening the common $\chi^{2}$ tests" 10 : 417-451, 1954

10 Dorsey ER, "Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030" 68 : 384-386, 2007

11 Chen RC, "Prevalence, incidence, and mortality of PD: a door-to-door survey in Ilan county, Taiwan" 57 : 1679-1686, 2001

12 Seo WK, "Prevalence of Parkinson's disease in Korea" 14 : 1155-1157, 2007

13 Okada K, "Prevalence of Parkinson's disease in Izumo city, Japan" 36 : 340-344, 1990

14 Tan LC, "Prevalence of Parkinson disease in Singapore: Chinese vs Malays vs Indians" 62 : 1999-2004, 2004

15 Brown TP, "Pesticides and Parkinson's disease--is there a link?" 114 : 156-164, 2006

16 Dauer W, "Parkinson's disease: mechanisms and models" 39 : 889-909, 2003

17 Sulzer D, "Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease" 30 : 244-250, 2007

18 Diem-Zangerl A, "Mortality in Parkinson's disease: a 20-year followup study" 24 : 819-825, 2009

19 Louis ED, "Mortality from Parkinson disease" 54 : 260-264, 1997

20 Noyce AJ, "Meta-analysis of early nonmotor features and risk factors for Parkinson disease" 72 : 893-901, 2012

21 Choi BC, "Look before you leap: stratify before you standardize" 149 : 1087-1096, 1999

22 Van Den Eeden SK, "Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity" 157 : 1015-1022, 2003

23 Taba P, "Incidence of Parkinson's disease in estonia" 22 : 41-45, 2003

24 Driver JA, "Incidence and remaining lifetime risk of Parkinson disease in advanced age" 72 : 432-438, 2009

25 Hughes AJ, "Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease" 57 : 1497-1499, 2001

26 Kontis V, "Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble" 389 : 1323-1335, 2017

27 Golbe LI, "Follow-up study of early-life protective and risk factors in Parkinson's disease" 5 : 66-70, 1990

28 안수정, "Femur Fractures in Parkinsonism: Analysis of a National Sample Cohort in South Korea" 대한신경과학회 13 (13): 380-386, 2017

29 Ishihara LS, "Estimated life expectancy of Parkinson's patients compared with the UK population" 78 : 1304-1309, 2007

30 Ho SC, "Epidemiologic study of Parkinson's disease in Hong Kong" 39 : 1314-1318, 1989

31 Spiegelman M, "Empirical testing of standards for the age adjustment of death rates by the direct method" 38 : 280-292, 1966

32 Joutsa J, "Diagnostic accuracy of parkinsonism syndromes by general neurologists" 20 : 840-844, 2014

33 Yamawaki M, "Changes in prevalence and incidence of Parkinson's disease in Japan during a quarter of a century" 32 : 263-269, 2009

34 Huse DM, "Burden of illness in Parkinson's disease" 20 : 1449-1454, 2005

35 Hughes AJ, "Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases" 55 : 181-184, 1992

36 Rajput AH, "Accuracy of clinical diagnosis in parkinsonism--a prospective study" 18 : 275-278, 1991

37 Priyadarshi A, "A meta-analysis of Parkinson's disease and exposure to pesticides" 21 : 435-440, 2000